Carcinogenesis

On this page
  1. Direct answer
  2. What you must remember
  3. A worked example — aflatoxin and the liver
  4. Where students slip
  5. Frequently asked questions
  6. Related topics

Direct answer

Carcinogenesis proceeds through initiation, promotion and progression — irreversible DNA mutation in a single cell, followed by clonal expansion driven by reversible promoter stimuli, and finally additional hits yielding genomic instability and invasive capability. Two gene classes carry the process: proto-oncogenes activated by gain-of-function (one mutated allele suffices, as with RAS) and tumour suppressor genes inactivated by loss of function (both alleles must go, per Knudson's two-hit hypothesis, as with RB and p53). Chemical carcinogens, radiation and microbes each leave recognisable signatures, and the stepwise accumulation of mutations — not a single event — explains the long latency and age gradient of cancer.

What you must remember

  • Initiation is irreversible; promotion is reversible (which is why stopping exposure, such as smoking cessation, still lowers risk late); progression to malignancy adds mutations and karyotypic instability.
  • Direct-acting carcinogens need no metabolism (alkylating agents, acetylaminofluorene derivatives); indirect-acting procarcinogens require metabolic activation by cytochrome P450 systems — the basis of organ-specific toxicity.
  • Classic pairings examiners test: tobacco smoke with lung and bladder cancer; aflatoxin B1 (Aspergillus flavus, contaminated groundnut and grain) with p53 mutation and hepatocellular carcinoma; vinyl chloride with hepatic angiosarcoma; beta-naphthylamine and aniline dyes with transitional bladder carcinoma; asbestos with mesothelioma and bronchogenic carcinoma.
  • RAS is the most commonly mutated proto-oncogene in human cancer (a point mutation locking it in the GTP-bound active state).
  • Tumour suppressors: RB1 (first identified, retinoblastoma, cell-cycle gate at G1/S), TP53 (guardian of the genome, mutated in over half of cancers, causes cell-cycle arrest via p21), APC (familial polyposis, Wnt pathway), BRCA1/2 (DNA repair by homologous recombination).
  • Two-hit examples: retinoblastoma — familial cases carry one germline hit and need one somatic hit (early, bilateral), sporadic cases need two somatic hits in one cell (late, unilateral).
  • DNA repair syndromes predispose to malignancy: xeroderma pigmentosum (nucleotide excision repair failure, ultraviolet-induced skin cancers), ataxia telangiectasia (ATM, radiation sensitivity, leukaemia/lymphoma), Bloom and Fanconi syndromes, Lynch syndrome (mismatch repair, colorectal and endometrial cancer with microsatellite instability).
  • Tumour metabolism: Warburg effect — aerobic glycolysis even in the presence of oxygen, exploited by PET imaging with fluorodeoxyglucose.
  • Epigenetic mechanisms (DNA methylation of promoter CpG islands, histone modification) silence genes such as MLH1 without mutation.

A worked example — aflatoxin and the liver

Trace one carcinogen from exposure to tumour to see the whole framework operating. Aflatoxin B1, produced by Aspergillus flavus on improperly stored groundnuts and maize, is a procarcinogen activated by hepatic cytochrome P450 to aflatoxin-8,9-epoxide. This metabolite forms adducts at codon 249 of TP53 — a characteristic G-to-T transversion producing a mutant "guardian" that cannot arrest the cell cycle or trigger apoptosis of damaged hepatocytes. The affected clone survives with genomic instability, and in a chronically inflamed, regenerating liver (usually one already harbouring hepatitis B) the clone accumulates further hits. The result, after years of latency, is hepatocellular carcinoma — and the R249S p53 mutation is a molecular fingerprint that pathologists can detect in tumours from high-exposure regions, including parts of India.

Now set the general rules alongside this story. The chemical acted as an initiator because it mutated DNA irreversibly; chronic hepatitis acted as a promoter, driving proliferation that clonally expanded the mutant cell; further mutations in oncogenes and repair genes delivered progression to invasion. The same logic maps onto vinyl chloride (activated to chloroethylene oxide, causing hepatic angiosarcoma in polyvinyl chloride workers) and aromatic amines (bladder urothelium activates and concentrates the metabolites in urine). This is why industrial histories belong in every oncology work-up, and why "exposure latency of decades" is expected, not surprising.

Where students slip

Two concepts get mangled in exams. First, oncogene versus tumour suppressor dosage: RAS or MYC needs only one activated allele (dominant at the cellular level), while RB, p53 and APC need both alleles disabled — so an inherited RB mutation behaves as a dominant trait at the family level even though it is recessive at the cellular level, a distinction examiners probe directly. Second, promotion is reversible: a promoter like phenobarbital or chronic irritation expands initiated clones but does not mutate them, so removing the promoter halts the process — the biological justification behind smoking cessation and betel-quid cessation campaigns in India's national cancer control programme. Candidates also misattribute mesothelioma risk (asbestos, especially amphibole/crocidolite fibres) and forget that asbestos multiplies rather than merely adds to tobacco's lung-cancer risk.

Frequently asked questions

What are the three sequential steps of chemical carcinogenesis?

Initiation (irreversible DNA mutation), promotion (reversible clonal proliferation of initiated cells) and progression (acquisition of further mutations and instability).

Which gene is most commonly mutated in human cancers and what is its function?

TP53, the guardian of the genome, which arrests the cell cycle through p21 and triggers apoptosis or repair in response to DNA damage.

How does aflatoxin B1 cause hepatocellular carcinoma?

Hepatic P450 activation to an epoxide that mutates TP53 at codon 249, a signature lesion in tumours from aflatoxin-exposed populations.

What distinguishes a proto-oncogene from a tumour suppressor gene mechanistically?

Proto-oncogenes promote growth when activated by gain-of-function on one allele; tumour suppressors permit growth only when both alleles are lost, per Knudson's two-hit hypothesis.

Which DNA repair deficiency predisposes to ultraviolet-induced skin cancer?

Xeroderma pigmentosum, failure of nucleotide excision repair of pyrimidine dimers, with early-onset squamous and basal cell carcinomas.

Which occupational carcinogen causes hepatic angiosarcoma?

Vinyl chloride monomer in polyvinyl chloride manufacture, activated in the liver to a reactive chloroethylene oxide.

Same topic for other exams

Practise this in the PrepElephant app

Question banks, previous-year questions, mock tests and revision tools — for Carcinogenesis and NEET-PG Pathology. Free to start.

Get the free app WhatsApp